22 September 2022 : Clinical Research
Impact of Adherence with Disease-Modifying Therapies on All-Cause Mortality Rates Among Veterans with Multiple Sclerosis
Meheroz H. Rabadi12ABCDEF*, Kimberly Just1B, Chao Xu
3CDE
DOI: 10.12659/MSM.938116
Med Sci Monit 2022; 28:e938116
Table 3 Comparison of mortality in groups defined by adherence to disease-modifying therapies only for patients with relapsing-remitting multiple sclerosis.
| Survival | Overall (n=115) | Non-adherent (n=44) | Poor-adherence (n=10) | Good-adherence (n=61) | P-value | ||
|---|---|---|---|---|---|---|---|
| Non vs poor | None vs good | Good vs poor | |||||
| Alive | 107 (79.9%) | 37 (84.1%) | 10 (100%) | 60 (98.4%) | 0.326 | 0.01 | 1 |
| Dead | 8 (20.1%) | 7 (15.9%) | 0 (0%) | 1 (1.6%) | |||